BeOne Medicines (ONC) Other financing activities (2016 - 2026)
BeOne Medicines (ONC) reported Other financing activities of -$3.2 million for Q1 2026, down 8.3% on a QoQ basis from -$3.0 million in Q4 2024.
BeOne Medicines (ONC) has 6 years of Other financing activities data on file, last reported at -$3.2 million in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to -$3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 8.3% YoY) and the FY2019 annual result came in at $4.0 million, changed N/A from the prior year.
- Other financing activities slipped to -$3.2 million in Q1 2026 per ONC's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Other financing activities topped out at -$3.0 million in Q4 2024 and bottomed at -$3.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.25 Mn |
| Mar 31, 2026 | -3.25 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Dec 31, 2018 | -414,000.00 |
| Dec 31, 2018 | -414,000.00 |
| Sep 30, 2018 | 414,000.00 |
| Sep 30, 2018 | 414,000.00 |
| Jun 30, 2018 | -414,000.00 |
| Jun 30, 2018 | -414,000.00 |
| Mar 31, 2018 | 414,000.00 |
| Mar 31, 2018 | 414,000.00 |
| Dec 31, 2017 | -13.85 Mn |
| Dec 31, 2017 | -13.85 Mn |
| Dec 31, 2016 | 740,000.00 |
| Dec 31, 2016 | 740,000.00 |
| Mar 31, 2016 | 1.48 Mn |
| Mar 31, 2016 | 1.48 Mn |